PegBio jumps most in 7 months on deal with Shanghai Tenry

Pegbio

17/03/2026 03:34

** China-based PegBio Co 2565.HK shares jump as much as 20.3% to HK$65.15, set for biggest one-day pct rise since August 15, 2025

** Innovative therapies developer's stock hit the highest point since March 9

** PegBio said it has entered into an exclusive commercialization collaboration with Shanghai Tenry Pharmaceutical for the company's core product Paidakang for treatment of type 2 diabetes in China

** Tenry Pharmaceutical will pay royalty totaling HK$140 million ($17.87 million) to the company - Co

** YTD, stock down 17.6%, while Hang Seng Biotech Index .HSBIO climbs 3.8%

($1 = 7.8322 Hong Kong dollars)

(Reporting by Donny Kwok)

((donny.kwok@thomsonreuters.com))